-
Product Insights
NewVasoactive Intestinal Polypeptide Receptor 2 – Drugs In Development, 2024
The Vasoactive Intestinal Polypeptide Receptor 2 pipeline drugs market research report outlays comprehensive information on the Vasoactive Intestinal Polypeptide Receptor 2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Respiratory, Immunology, and Genetic Disorders which include indications of Parkinson's Disease, Schizophrenia, Acute Respiratory Distress Syndrome, Cystic Fibrosis, Sarcoidosis, Pulmonary Sarcoidosis, and Duchenne Muscular Dystrophy....
-
Product Insights
NewAlpha 2 Adrenergic Receptor – Drugs In Development, 2024
The Alpha 2 Adrenergic Receptor pipeline drugs market research report outlays comprehensive information on the Alpha 2 Adrenergic Receptor targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Ophthalmology, Immunology, and Infectious Disease which include indications of Schizophrenia, Dementia Associated With Alzheimer's Disease, Presbyopia, Glaucoma, Anaphylaxis, Sepsis, and Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress...
-
Product Insights
NewInterferon Alpha/Beta Receptor 1 – Drugs In Development, 2024
The Interferon Alpha/Beta Receptor 1 pipeline drugs market research report outlays comprehensive information on the Interferon Alpha/Beta Receptor 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Infectious Disease, Oncology, Respiratory, and Central Nervous System which include indications of Coronavirus Disease 2019 (COVID-19), Hepatitis B, Oncology, Solid Tumor, Pneumonia, Acute Respiratory Distress Syndrome, Multiple Sclerosis, and Demyelinating...
-
Product Insights
NewInterferon Alpha/Beta Receptor 2 – Drugs In Development, 2024
The Interferon Alpha/Beta Receptor 2 pipeline drugs market research report outlays comprehensive information on the Interferon Alpha/Beta Receptor 2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Infectious Disease, Oncology, Respiratory, and Central Nervous System which include indications of Coronavirus Disease 2019 (COVID-19), Hepatitis B, Oncology, Hepatocellular Carcinoma, Acute Respiratory Distress Syndrome, Chronic Obstructive Pulmonary Disease (COPD),...
-
Product Insights
NewPhosphodiesterase 3 – Drugs In Development, 2024
The Phosphodiesterase 3 pipeline drugs market research report outlays comprehensive information on the Phosphodiesterase 3 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Cardiovascular, Respiratory, Infectious Disease, and Oncology which include indications of Cardiovascular, Acute Coronary Syndrome, Chronic Obstructive Pulmonary Disease (COPD), Idiopathic Pulmonary Fibrosis, Coronavirus Disease 2019 (COVID-19), Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syndrome,...
-
Product Insights
NewComplement C1s Subcomponent – Drugs In Development, 2024
The Complement C1s Subcomponent pipeline drugs market research report outlays comprehensive information on the Complement C1s Subcomponent targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Immunology, Central Nervous System, Hematological Disorders, and Infectious Disease which include indications of Autoimmune Disorders, Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency), Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Polyradiculoneuropathy, Acquired (Autoimmune) Hemolytic...
-
Product Insights
NewAmine Oxidase [Flavin Containing] B – Drugs In Development, 2024
The Amine Oxidase [Flavin Containing] B pipeline drugs market research report outlays comprehensive information on the Amine Oxidase [Flavin Containing] B targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Infectious Disease, Immunology, and Genetic Disorders which include indications of Parkinson's Disease, Alzheimer's Disease, Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syndrome, Coronavirus Disease 2019...
-
Product Insights
NewTransmembrane Protease Serine 2 – Drugs In Development, 2024
The Transmembrane Protease Serine 2 pipeline drugs market research report outlays comprehensive information on the Transmembrane Protease Serine 2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Infectious Disease, Respiratory, Hematological Disorders, and Gastrointestinal which include indications of Coronavirus Disease 2019 (COVID-19), Coronavirus Disease 2019 (COVID-19) Pneumonia, Pneumonia, Acute Respiratory Distress Syndrome, Disseminated Intravascular Coagulation (DIC), and...
-
Product Insights
NewApelin Receptor – Drugs In Development, 2024
The Apelin Receptor pipeline drugs market research report outlays comprehensive information on the Apelin Receptor targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Metabolic Disorders, Cardiovascular, Central Nervous System, and Infectious Disease which include indications of Obesity, Type 2 Diabetes, Pulmonary Arterial Hypertension, Unspecified Central Nervous System Disorders, Cognitive Disorders, Coronavirus Disease 2019 (COVID-19), and Coronavirus Disease...
-
Product Insights
NewProtein Kinase B – Drugs In Development, 2024
The Protein Kinase B pipeline drugs market research report outlays comprehensive information on the Protein Kinase B targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Cardiovascular, Central Nervous System, and Infectious Disease which include indications of Solid Tumor, Triple-Negative Breast Cancer (TNBC), Cardiovascular, Acute Ischemic Stroke, Parkinson's Disease, Unspecified Neurologic Disorders, Tuberculosis, and Coronavirus Disease 2019...